HLB CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 89,700 KRW | -4.27% |
|
+9.26% | +76.92% |
| Jul. 04 | HLB Stock Soars Amid FDA Re-Approval Efforts for Liver Cancer Drug | MT |
| Jun. 25 | HLB Co., Ltd. announced that it expects to receive KRW 33 billion in funding from F&F Co., Ltd | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| HLB CO., LTD. | Other Medical Equipment, Supplies & Distribution | -4.27% | +9.26% | +76.92% | +202.36% | +561.91% | 8.55B |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- A028300 Stock
- Charts HLB Co., Ltd.
- Comparison Chart